January marked a flurry of resignations among the highest ranks of Kodak leadership. On Jan. 7, the company announced that Patricia F. Russo had resigned as president and COO to become CEO of Lucent Technologies. Less than a week earlier, Kodak senior
January marked a flurry of resignations among the highest ranks of Kodak leadership. On Jan. 7, the company announced that Patricia F. Russo had resigned as president and COO to become CEO of Lucent Technologies. Less than a week earlier, Kodak senior vice president J. Michael McQuade said he would step down as president of Kodak's Health Imaging unit to become a vice president of 3M's medical products division. Kodak chairman of the board and CEO Daniel A. Carp has assumed the responsibilities of Kodak president and COO. Candy M. Obourn, as COO of the company's Health Imaging unit, has assumed McQuade's duties. The search has begun for a new president of the Health Imaging unit.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.